IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0086667
(2011-04-14)
|
등록번호 |
US-8761884
(2014-06-24)
|
발명자
/ 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
103 |
초록
▼
A system and method for estimating the longevity of an implantable medical device (IMD). In one embodiment of a method for estimating a life of a power source of an implantable medical device, a first life estimate of the power source is determined based on a first open-loop value corresponding to a
A system and method for estimating the longevity of an implantable medical device (IMD). In one embodiment of a method for estimating a life of a power source of an implantable medical device, a first life estimate of the power source is determined based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, and prior usage data corresponding to prior therapy delivery. The first life estimate of the power source is displayed. The first life estimate displayed includes a first open-loop portion associated with open-loop therapy delivery and a first closed-loop portion associated with closed-loop therapy delivery.
대표청구항
▼
1. A method for estimating a life of a power source of an implantable medical device (IMD), the method comprising: determining a first life estimate of the power source based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed-loop value
1. A method for estimating a life of a power source of an implantable medical device (IMD), the method comprising: determining a first life estimate of the power source based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed-loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, a second closed-loop value corresponding to manually-initiated therapy delivery where the manually-initiated therapy delivery was initiated by a patient, and prior usage data corresponding to prior therapy delivery;displaying one or more automatic close-loop therapy energy usages;displaying one or more automatic close-loop detection sensitivity options; andmodifying an automatic close-loop detection sensitivity based on at least one of the one or more automatic close-loop therapy energy usages and the one or more automatic close-loop detection sensitivity options. 2. The method of claim 1, wherein the step of modifying the automatic close-loop detection sensitivity is to reduce the automatic close-loop detection sensitivity based on at least one of the one or more automatic close-loop therapy energy usages and the one or more automatic close-loop detection sensitivity options. 3. The method of claim 1, wherein the second closed-loop portion associated with the manually-initiated therapy delivery is different from the first closed-loop portion associated with the closed-loop therapy delivery. 4. The method of claim 1, further comprising: receiving a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;determining a second life estimate of the power source based on the second open-loop value, the first closed-loop value, and the prior usage data; anddisplaying the second life estimate of the power source, the second life estimate having the first closed-loop portion and a second open-loop portion, wherein the second open-loop portion is different from the first open-loop portion. 5. The method of claim 1, further comprising: receiving a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;receiving the second closed-loop value corresponding to the manually-initiated therapy delivery, wherein the second closed-loop value is different from the first closed-loop value;determining a second life estimate of the power source based on the second open-loop value, the second closed-loop value, and the prior usage data. 6. The method of claim 1, wherein the prior usage data includes at least one of prior usage rates of the power source and a number of closed-loop therapies delivered. 7. The method of claim 1, wherein the open-loop therapy delivery and the closed-loop therapy delivery each comprise delivery of an electrical stimulation to a structure in a patient's body. 8. An implantable medical device (IMD) comprising: one or more memory modules; andone or more processors configured to estimate a life of a power source of the IMD by:determining a first life estimate of the power source based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed-loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, a second closed-loop value corresponding to manually-initiated therapy delivery where the manually-initiated therapy delivery was initiated by a patient, and prior usage data corresponding to prior therapy delivery;displaying via an external display one or more automatic close-loop therapy energy usages;displaying via the external display one or more automatic close-loop detection sensitivity options; andmodifying an automatic close-loop detection sensitivity based on at least one of theone or more automatic close-loop therapy energy usages and the one or moreautomatic close-loop detection sensitivity options. 9. The IMD of claim 8, wherein the one or more processors are further configured to modify the automatic close-loop detection sensitivity by reducing the automatic close-loop detection sensitivity based on at least one of the one or more automatic close-loop therapy energy usages and the one or more automatic close-loop detection sensitivity options. 10. The IMD of claim 8, wherein the second closed-loop portion associated with the manually-initiated therapy delivery is different from the first closed-loop portion associated with the closed-loop therapy delivery. 11. The IMD of claim 8, wherein the one or more processors are further configured to: receive a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;determine a second life estimate of the power source based on the second open-loop value, the first closed-loop value, and the prior usage data; anddisplay the second life estimate of the power source, the second life estimate having the first closed-loop portion and a second open-loop portion, wherein the second open-loop portion is different from the first open-loop portion. 12. The IMD of claim 8, wherein the one or more processors are further configured to: receive a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;receive the second closed-loop value corresponding to the manually-initiated therapy delivery, wherein the second closed-loop value is different from the first closed-loop value;determine a second life estimate of the power source based on the second open-loop value, the second closed-loop value, and the prior usage data. 13. The IMD of claim 8, wherein the prior usage data includes at least one of prior usage rates of the power source and a number of closed-loop therapies delivered. 14. The IMD of claim 8, wherein the open-loop therapy delivery and the closed-loop therapy delivery each comprise delivery of an electrical stimulation to a structure in a patient's body. 15. A medical system comprising: one or more external computing devices; andone or more implantable medical devices where the one or more implantable medical devices each include one or more memory modules and one or more processors configured to estimate a life of a power source for the implantable medical device by:determining a first life estimate of the power source based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed-loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, a second closed-loop value corresponding to manually-initiated therapy delivery where the manually-initiated therapy delivery was initiated by a patient, and prior usage data corresponding to prior therapy delivery;displaying via the one or more external computing devices one or more automatic close-loop therapy energy usages;displaying via the one or more external computing devices one or more automatic close-loop detection sensitivity options; andmodifying an automatic close-loop detection sensitivity based on at least one of the one or more automatic close-loop therapy energy usages and the one or more automatic close-loop detection sensitivity options. 16. The system of claim 14, wherein the one or more processors are further configured to modify the automatic close-loop detection sensitivity by reducing the automatic close-loop detection sensitivity based on at least one of the one or more automatic close-loop therapy energy usages and the one or more automatic close-loop detection sensitivity options. 17. The system of claim 14, wherein the second closed-loop portion associated with the manually-initiated therapy delivery is different from the first closed-loop portion associated with the closed-loop therapy delivery. 18. The system of claim 14, wherein the one or more processors are further configured to: receive a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;determine a second life estimate of the power source based on the second open-loop value, the first closed-loop value, and the prior usage data; anddisplay the second life estimate of the power source, the second life estimate having the first closed-loop portion and a second open-loop portion, wherein the second open-loop portion is different from the first open-loop portion. 19. The system of claim 14, wherein the one or more processors are further configured to: receive a second open-loop value corresponding to the open-loop parameter, wherein the second open-loop value is different from the first open-loop value;receive the second closed-loop value corresponding to the manually-initiated therapy delivery, wherein the second closed-loop value is different from the first closed-loop value;determine a second life estimate of the power source based on the second open-loop value, the second closed-loop value, and the prior usage data. 20. The system of claim 14, wherein the prior usage data includes at least one of prior usage rates of the power source and a number of closed-loop therapies delivered. 21. The system of claim 14, wherein the open-loop therapy delivery and the closed-loop therapy delivery each comprise delivery of an electrical stimulation to a structure in a patient's body.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.